A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD

NCT01761292 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy (DMD)

Interventions

DRUG: Givinostat

Sponsor

Italfarmaco